Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and pharmacokinetics of CKD-330
(fixed-dose combination of Candesartan 8 mg and Amlodipine 5 mg) with coadministration of the
two separate drugs in healthy male volunteers.